Otrivin Duo (Xylometazoline Hydrochloride, Ipratropium Bromide)

Xylometazoline hydrochloride, the active ingredient in Otrivin Duo, is a nasal decongestant presented as a combination formulation for intranasal use. It relieves nasal congestion associated with colds, sinusitis and allergic rhinitis in adults and children. GNH USA supplies Otrivin Duo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Otrivin Duo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Otrivin Duo combines both a decongestant and an anticholinergic to address nasal obstruction and rhinorrhoea. It is indicated for: - Common cold: reduces nasal blockage and runny nose. - Acute sinusitis: improves nasal airflow and drainage. - Allergic rhinitis: lessens congestion and post‑nasal drip. - Seasonal allergy flare‑ups: provides rapid relief of nasal symptoms. - Upper respiratory tract infections: eases nasal passage swelling.

Side effects are generally mild and related to local nasal irritation.

Common Side Effects: - Nasal burning or stinging sensation. - Mild headache. - Dryness of the nasal mucosa. - Sneezing. - Transient taste disturbance.

Serious or Rare Side Effects: - Persistent nasal irritation or ulceration. - Severe headache or facial pain. - Hypertensive crisis in susceptible individuals. - Allergic reaction such as rash, itching or swelling. - Nasal septum perforation. - Vision changes.

Before using Otrivin Duo, consider the following safety measures: - Contraindications: Do not use if you have any ​     ...   - Pregnancy  …  ...  t…   t  t  \

This       """  "" "" """  ""